Topics

Sandeep Dhindsa, MD, has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.

Researchers at UB have developed a novel technology that is expected to have implications for research and treatment of tuberculosis and other lung diseases.

A paper published by William Ruyechan, PhD, is being reviewed by Faculty of 1000 (F1000), a service that identifies and evaluates the most important articles in biology and medical research publications.

Paresh Dandona, MD, Distinguished Professor of Medicine, has been named the 2010 recipient of the Presidential Award for Faculty Excellence.

Thomas Melendy, PhD, received an award for best overall presentation at the International Papillomavirus Conference.

A UB MD/PhD candidate is lead author on a paper describing how drug-resistant viruses may be thwarted by a potent, immune-boosting payload delivered to cells by gold nanorods.

Vietnam War-era veterans exposed to Agent Orange appear to have significantly more Graves’ disease, a thyroid disorder, than veterans with no exposure.

UB medical students “passed the hat” and organized events to raise funds for Haiti in the aftermath of the massive earthquake in January 2010.

The Cystic Fibrosis Center at Women and Children’s Hospital of Buffalo, a UB-affiliated teaching hospital, is the first U.S. site to begin recruiting patients for a study of a promising investigational treatment for cystic fibrosis.